Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-17 Sale | 2024-05-21 5:35 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director | 1,106 | $141.9 | $156,943 | 994 (Direct) | View |
| 2020-10-14 Sale | 2020-10-16 7:15 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini EVP, Finance | 375 | $87.99 | $32,996 | 97,812 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 2:11 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 14,378 | $88.4 | $1,271,073 | 129,311 (Direct) | View |
| 2020-06-03 Sale | 2020-06-05 4:59 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 12,798 | $74.19 | $949,431 | 141,734 (Direct) | View |
| 2020-05-18 Sale | 2020-05-20 7:49 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 29,113 | $73.33 | $2,134,885 | 138,242 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-24 9:28 pm | N/A 2034-01-23 | Septerna Inc. | SEPN | Sharp Shalini Director | 0 | $0 | 52,261 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 7:21 pm | N/A 2034-09-29 | BeiGene Ltd. | BGNE | Sharp Shalini Director | 25,389 | $0 | 25,389 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 3:17 pm | N/A N/A | Organon & Co. | OGN | Sharp Shalini Director | 9,639 | $20.75 | 36,784 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 6:34 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director | 4,417 | $0 | 4,417 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 5:35 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director | 2,100 | $0 | 994 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:38 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 23,742 | $0 | 0 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:24 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 6,808 | $58.75 | 16,222 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:00 pm | N/A N/A | Organon & Co. | OGN | Sharp Shalini Director | 10,086 | $19.83 | 25,596 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 5:22 pm | N/A 2033-05-17 | NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director | 6,390 | $0 | 6,390 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:03 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 11,964 | $0 | 16,934 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 7:42 pm | N/A N/A | Organon & Co. | OGN | Sharp Shalini Director | 5,640 | $35.46 | 14,937 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 7:10 pm | N/A 2032-06-05 | SUTRO BIOPHARMA INC. | STRO | Sharp Shalini Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 4:16 pm | N/A 2032-05-18 | NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director | 9,724 | $0 | 9,724 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 6:17 pm | N/A 2032-01-13 | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 6,234 | $0 | 8,658 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 8:31 pm | N/A N/A | Organon & Co. | OGN | Sharp Shalini Director | 9,061 | $36.05 | 9,063 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 5:07 pm | N/A 2031-06-02 | SUTRO BIOPHARMA INC. | STRO | Sharp Shalini Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:12 pm | 2021-06-19 2031-05-19 | NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director | 8,833 | $0 | 8,833 (Direct) | View |
| 2021-05-10 Option Award | 2021-05-12 4:09 pm | N/A 2031-05-09 | PRECISION BIOSCIENCES INC | DTIL | Sharp Shalini Director | 32,800 | $0 | 32,800 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 5:41 pm | N/A 2031-03-25 | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 5,947 | $0 | 5,947 (Direct) | View |
Ownership | 2021-03-30 5:41 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 0 | $0 | 0 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-26 7:02 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Sharp Shalini Director | 10,000 | $10 | 35,000 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-26 7:02 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Sharp Shalini Director | 25,000 | $0 | 35,000 (Direct) | View |
| 2020-08-17 Exercise | 2020-08-19 2:11 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 3,669 | $48.43 | 129,311 (Direct) | View |
| 2020-08-17 Exercise | 2020-08-19 2:11 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 500 | $70.57 | 129,311 (Direct) | View |
| 2020-08-17 Exercise | 2020-08-19 2:11 pm | N/A 2026-06-01 | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 11,357 | $0 | 129,311 (Direct) | View |
| 2020-08-17 Exercise | 2020-08-19 2:11 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 7,188 | $67.55 | 129,311 (Direct) | View |
Ownership | 2020-06-30 6:11 pm | N/A N/A | Panacea Acquisition Corp | PANA | Sharp Shalini Director | 0 | $0 | 25,000 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-08 5:36 pm | N/A 2030-06-04 | SUTRO BIOPHARMA INC. | STRO | Sharp Shalini Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-06-03 Exercise | 2020-06-05 4:59 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 12,798 | $48.43 | 141,734 (Direct) | View |
| 2020-06-03 Exercise | 2020-06-05 4:59 pm | N/A 2028-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 12,798 | $0 | 141,734 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 2:19 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 348 | $69.38 | 101,208 (Direct) | View |
| 2020-05-19 Exercise | 2020-05-20 7:49 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 3,221 | $48.43 | 138,242 (Direct) | View |
| 2020-05-18 Exercise | 2020-05-20 7:49 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 23,500 | $70.57 | 138,242 (Direct) | View |
| 2020-05-18 Exercise | 2020-05-20 7:49 pm | N/A 2026-06-01 | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 26,721 | $0 | 138,242 (Direct) | View |
| 2020-05-13 Option Award | 2020-05-15 4:00 pm | N/A 2030-05-12 | PRECISION BIOSCIENCES INC | DTIL | Sharp Shalini Director | 41,038 | $0 | 41,038 (Direct) | View |
| 2020-05-06 Tax Withholding | 2020-05-08 7:55 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 248 | $66.26 | 103,336 (Direct) | View |
| 2020-04-19 Tax Withholding | 2020-04-21 3:39 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 248 | $58.57 | 103,584 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 7:46 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 5,634 | $0 | 103,832 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 7:46 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President | 2,325 | $56.08 | 103,832 (Direct) | View |
| 2020-02-01 Option Award | 2020-02-04 4:34 pm | N/A 2030-02-01 | NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director | 15,000 | $0 | 15,000 (Direct) | View |